| Literature DB >> 29028841 |
Anaiá da Paixão Sevá1, Maia Martcheva1, Necibe Tuncer2, Isabella Fontana3, Eugenia Carrillo4, Javier Moreno4, James Keesling1.
Abstract
Leishmaniasis is a vector-borne disease of worldwide distribution, currently present in 98 countries. Since late 2010, an unusual increase of human visceral and cutaneous leishmaniasis cases has been observed in the south-western Madrid region, totaling more than 600 cases until 2015. Some hosts, such as human, domestic dog and cat, rabbit (Oryctolagus cuniculus), and hare (Lepus granatensis), were found infected by the parasite of this disease in the area. Hares were described as the most important reservoir due to their higher prevalence, capacity to infect the vector, and presence of the same strains as in humans. Various measures were adopted to prevent and control the disease, and since 2013 there was a slight decline in the human sickness. We used a mathematical model to evaluate the efficacy of each measure in reducing the number of infected hosts. We identified in the present model that culling both hares and rabbits, without immediate reposition of the animals, was the best measure adopted, decreasing the proportion of all infected hosts. Particularly, culling hares was more efficacious than culling rabbits to reduce the proportion of infected individuals of all hosts. Likewise, lowering vector contact with hares highly influenced the reduction of the proportion of infected hosts. The reduction of the vector density per host in the park decreased the leishmaniasis incidence of hosts in the park and the urban areas. On the other hand, the reduction of the vector density per host of the urban area (humans, dogs and cats) decreased only their affected population, albeit at a higher proportion. The use of insecticide-impregnated collar and vaccination in dogs affected only the infected dogs' population. The parameters related to the vector contact with dog, cat or human do not present a high impact on the other hosts infected by Leishmania. In conclusion, the efficacy of each control strategy was determined, in order to direct future actions in this and in other similar outbreaks. The present mathematical model was able to reproduce the leishmaniasis dynamics in the Madrid outbreak, providing theoretical support based on successful experiences, such as the reduction of human cases in Southwest Madrid, Spain.Entities:
Mesh:
Year: 2017 PMID: 29028841 PMCID: PMC5640254 DOI: 10.1371/journal.pone.0186372
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Model of the leishmaniasis dynamic.
Vector: V1) Non infected, V2) Infected but not infective; V3) Infected and infective; Human: Sh) Susceptible; Dct) Sick with cutaneous leishmaniasis; Lv) Latent with visceral leishmaniasis, Ahr and Ahd) Asymptomatic; Dv) Sick with visceral leishmaniasis; Tv) Visceral leishmaniasis in treatment; Rc and Rvc) Recovered; Dogs and Cats: S) Susceptible; L) Latent with visceral leishmaniasis, A) Asymptomatic; D) Sick with visceral leishmaniasis; R) Recovered; Hares and Rabbits: S) Susceptible; I) Infectious; R) Recovered.
Parameters of the model and its symbols, biological meanings, values, and references.
| P | BIOLOGICAL MEANING | VALUE | SOURCE |
|---|---|---|---|
| pc | proportion of infections that evolve to CL | 0.635 | [ |
| pv | proportion of infections that evolve to VL | 0.365 | [ |
| Time to appearance of symptoms in humans | 2–6 months (PI = 1day-1year) | [ | |
| Lethality in sick humans | 0.0331 | [ | |
| Period with symptoms of VL | 25 days (9–41) + 30 days | [ | |
| Symptoms period of CL | 109 days (35–183) (até tto) + 15 days (tto) | [ | |
| Recovery period of VL | 10 years | Estimated based on Badaro et al., Carvalho et al., Alvar [ | |
| Recovery period of CL | 10 years | Estimated based on [ | |
| Recovery time of treated individuals | 2 years | Estimated based on Carvalho et al., Silva et al., Alvar. [ | |
| Recovery period of humans with asymptomatic VL | 22 months | Estimated based on Viana et al. [ | |
| Proportion of humans that develop asymptomatic VL | 0.8 | [ | |
| Proportion of humans that develop symptomatic VL | 0.2 | [ | |
| Natural death rate of humans | 1/83.3 years-1 | [ | |
| Recovery time of dogs with asymptomatic VL | 1 year | Estimated based on Fisa et al., Silva et al. [ | |
| Time to recover from VL | 2 year | Estimated based on Garcia et al. and Pozio et al. [ | |
| Time to appearance of symptoms in dogs | 2 months | [ | |
| Symptomatic period of VL in dogs | 1 year | [ | |
| Lethality in sick dogs | 0.88 | [ | |
| Proportion of dogs that develop asymptomatic VL | 0.62 | [ | |
| Proportion of dogs that develop symptomatic VL | 0.38 | [ | |
| Natural death rate of dogs | 0.067 years-1 | [ | |
| Vaccine coverage | E x Coverage | ||
| Period of vaccine protection | 1 year | ||
| Vaccine efficacy | 0.70 | [ | |
| Insecticide impregnated collar coverage | Coverage | ||
| Period of collar protection | 6 months | [ | |
| Collar insecticide efficacy | 0.55 | [ | |
| Collar repellent effect | 0.90 | [ | |
| Time to appearance of symptoms in cats | 2 months | [ | |
| Recover period of VL | 2 year | Estimated based on Garcia et al. and Pozio et al. [ | |
| Symptomatic period of VL in cats | 1 year | Estimated based on Pozio et al. [ | |
| Recovery period of cats with asymptomatic VL | 1 year | Estimated based on Fisa et al., Silva et al. [ | |
| Proportion of cats that develop asymptomatic VL | 0.62 | Estimated based on Miró et al. [ | |
| Proportion of cats that develop symptomatic VL | 0.38 | Estimated based on Miró et al. [ | |
| Natural death rate of cats | 0.067 year-1 | Estimated based on Bouza [ | |
| Latency period in humans, dogs and cats | 0.005 days | [ | |
| Recovery period of VL | 6 months | Estimated | |
| Symptomatic period of VL in hares | 1 year | Estimated based on Galvez et al. [ | |
| Natural death rate of hares | 0.083 year-1 | [ | |
| Recovery period of VL | 6 months | Estimated | |
| Symptomatic period of VL in rabbits | 1 year | Estimated based on Galvez et al. [ | |
| Natural death rate of rabbits | 0.01 year-1 | [ | |
| Rate of infective bites | 0.01 | [ | |
| Daily bites of vector on humans* blood meal rate | 60.83*0.03 | [ | |
| Daily bites of vector on dogs*blood meal rate | 60.83*0.05 | [ | |
| Daily bites of vector on cats*blood meal rate | 60.83*0.05 | [ | |
| Daily bites of vector on hares*blood meal rate | 60.83*0.6 | [ | |
| Daily bites of vector on rabbits*blood meal rate | 60.83*0.6 | [ | |
| Death rate of V2 | 0.16 days | Estimated | |
| Daily bites of vector on collar-wearing dogs*blood meal rate * (1 –CE) | (60.83*0.05)*0.1 | ||
| Death rate of V3 | 1 day | Estimated | |
| Gonadotrophic period | 6 days | [ | |
| Proportion of the vectors that acquire infection biting humans | 0.6% | [ | |
| Proportion of the vectors that acquire infection biting dogs | 32% | [ | |
| Proportion of the vectors that acquire infection biting cats | 4% | [ | |
| Proportion of the vectors that acquire infection biting hares | 4.7% | [ | |
| Proportion of the vectors that acquire infection biting rabbits | 1% | [ | |
| Vector per humans | 0.003 | Estimate | |
| Vector per dogs | 0.1 | Estimate | |
| Vector per cats | 0.4 | Estimate | |
| Vector per hares | 2 | Estimate | |
| Vector per rabbits | 0.5 | Estimate | |
P) Parameter symbols. The parameter “daily bites of vectors per hosts” (a) consist in the extrinsic incubation period associated with the blood meal rate of the different host species
The influence of the measures in the decrease of the proportion of infected population incidences (infected after/before interventions).
| Interventions | cover | HUMANS (Sick %) | DOGS | CATS | HARES | RABBITS | Protected dogs by vaccine |
|---|---|---|---|---|---|---|---|
| Population without use of control measures | 0.0101 | 2.36 | 6.19 | 60.77 | 46.54 | 0 | |
| kh+kr | 50% | 0.0099 | 2.32 | 6.09 | 60.09 | 40.40 | 0 |
| 75% | 0.0096 | 2.26 | 5.96 | 59.39 | 34.76 | 0 | |
| kh+kr (50% rr) | 50% | 0.0016 | 0.52 | 1.44 | 2.80 | 3.13 | 0 |
| 75% | 0.0002 | 0.08 | 0.22 | 0.20 | 0.26 | 0 | |
| kh (50% rr) | 50% | 0.0062 | 1.53 | 4.18 | 3.28 | 38.79 | 0 |
| 75% | 0.0057 | 1.39 | 3.85 | 0.30 | 37.44 | 0 | |
| kr (50% rr) | 50% | 0.0082 | 2.00 | 5.35 | 59.52 | 5.59 | 0 |
| 75% | 0.0084 | 1.94 | 5.20 | 59.31 | 1.35 | 0 | |
| Vaccine (Clin Eff = 18.5%) | 50% | 0.0101 | 1.53 | 6.18 | 60.76 | 46.51 | 27% |
| 75% | 0.0101 | 1.22 | 6.17 | 60.75 | 46.50 | 39% | |
| Collar | 50% | 0.0101 | 1.46 | 6.17 | 60.75 | 46.50 | 0 |
| 75% | 0.0100 | 1.02 | 6.17 | 60.75 | 46.49 | 0 |
Cover) Coverage or intensity of the measure effect; Seropos) Seropositives; kh) Culling hares; kr) Culling rabbits; rr) Reproductive rate; Clin Eff) Clinical vaccine efficacy; Seropos) Proportion of seropositive population; Sick) Proportion of sick population;
*At these coverages are being considered the reduction of 4.9% of loss and damage.
Fig 2Average variations in sick humans (A), and seroprevalence of dogs (B), cats (C), hares (D), and rabbits (E) in response to the 1% parameter variations.
cl, cr, cc, cd, ch) Rate of the vector acquiring infection biting hares, rabbits, cats, dogs, and humans, respectively; ρl, ρr, ρc, ρd, ρh) Density of the vector per hares, rabbits, cats, dogs, and humans, respectively; Reduction) Effect on infected hosts when the parameters are decreased; Increase) Effect on infected hosts when the parameters are increased.
The influence of insecticide of residual action in decreasing the proportion of infected population.
| Interventions | usage | HUMANS (Sick %) | DOGS | CATS | HARES | RABBITS |
|---|---|---|---|---|---|---|
| Population without use of control measures | 0.01 | 2.36 | 6.19 | 60.77 | 46.54 | |
| Insec. Park | 75% | 0.0074 | 1.77 | 3.75 | 56.14 | 37.04 |
| Insec. Urban | 75% | 0.0057 | 1.39 | 3.86 | 58.87 | 42.30 |
| dvec/h Park | 75% | 0.0098 | 2.31 | 4.79 | 58.60 | 41.74 |
| dvec/h Urban | 75% | 0.0076 | 1.80 | 4.89 | 60.76 | 46.51 |
Usage) Intensity of the measure effect; Insec. Park) Reduction of density of vector per host of park and life expectancy of vector; Insec. Urban) Reduction of density of vector per host of urban area and life expectancy of vector; dvec/h) Reduction of density of the vector per hosts; City) The hosts are the humans, dogs and cats; Park) The hosts are hares, rabbits and cats; Seropos) Proportion of seropositive population; Sick) Proportion of sick population.
Fig 3Global sensitivity analysis and its partial rank correlation coefficients (PRCC) of “Daily biting” and “vectors per hosts” parameters.
“Daily bites of vector on hosts” rate (ah, ad, ac, ar and al) and “vectors per host” rate (ρh, ρd, ρc, ρr and ρl), following the sequence of hosts: human, dog, cat, rabbits and hares.
Fig 4Global sensitivity analysis and its p-values of “Daily biting rates” and “vectors per host” parameters.
“Daily bites of vector on hosts” rate (ah, ad, ac, ar and al) and “vectors per host” rate (ρh, ρd, ρc, ρr and ρl), following the sequence of hosts: human, dog, cat, rabbits and hares.
Fig 5Human prevalences according the variations of the parameters “daily biting rate in humans” (ah) and “vector density per human” (ρh).
A) ah fixed at 1.8249 and ρh varied from 0.03 to 0.0003; B) ah fixed at 0.18249 and ρh varied from 0.03 to 0.0003; and C) ah fixed in 18.249 and ρh varied from 0.03 to 0.0003.